This Remuneration Report describes PolyPeptide’s remuneration governance and principles, structure and elements. We have prepared this report in compliance with the requirements of the Swiss Ordinance against Excessive Compensation with respect to Listed Stock Corporations (“OaEC”) as well as PolyPeptide Group AG’s Articles of Association and, with respect to compensation disclosure, in compliance with the SIX Swiss Exchange Directive on Information relating to Corporate Governance (“DCG”) and the Swiss Code of Best Practice for Corporate Governance issued by economiesuisse.